FDAnews
www.fdanews.com/articles/203203-teleglobals-chest-abnormality-detection-software-awarded-ce-mark
CE mark

Teleglobal’s Chest Abnormality Detection Software Awarded CE Mark

June 17, 2021

Teleglobal Consulting UK’s artificial intelligence software for detecting chest abnormalities has received a CE mark.

The software, sold under the brand name iDoc.ai, can detect 13 types of chest conditions, including those caused by COVID-19.

The software also has certification under ISO 13485, and is now available in Europe and other markets that accept the CE mark.

View today's stories